20505 ⎘
Medicinal preparations containing organic active ingredients; Phosphorus compounds Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
Method of reducing appetite in a human subject comprising administering krill oil composition
#302WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS
#303Composition for external use on skin for inflammatory diseases
#304Methods and compositions for enhancing oxygen levels in tissues
#305Modulators of toll-like receptors
#306Methods for the treatment of hepatitis B and hepatitis D virus infections
#307Phospholipid compound containing unsaturated fatty acid derivative having cyclopropane ring
#308Two-carbon linked artemisinin-derived trioxane dimers
#309Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies
#310Hypotonic aqueous composition with reduced chloride content, with or without phospholipids
#311Sphingomyelin-containing supplement
#312Flavored chewable lipid supplements for maintaining health and the treatment of acute and chronic disorders
#313Non-medical increase or maintenance of body weight of a mammal
#314Anti-HIV compound and preparation method and use thereof
#315Derivatives of indole for the treatment of cancer, viral infections and lung diseases
#316Lyophilization of synthetic liposomal pulmonary surfactant
#317Inhibition of HIV infection through chemoprophyalxis
#318Use of glycerophosphoinositols for the treatment of septic shock
#319Compositions and methods for treating addiction
#320Phosphonate compounds for treatment of complement mediated disorders
#321Ether compounds for treatment of complement mediated disorders
#322Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#323Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#324Amino compounds for treatment of complement mediated disorders
#325Amide compounds for treatment of complement mediated disorders
#326Alkyne compounds for treatment of complement mediated disorders
#327Compounds for treatment of complement mediated disorders
#328Factor D inhibitors useful for treating inflammatory disorders
#329OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH
#330Methods of treating patients co-infected with HIV and tuberculosis
#331METHODS AND MATERIALS FOR REDUCING RETICULOENDOTHELIAL SYSTEM CLEARANCE OF PARTICLES FROM A SUBJECT
#332Compositions for external application, containing adenosylcobalamin for improvement of skin diseases
#333Unitary pharmaceutical dosage form
#334Bioeffective krill oil compositions
#335ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION
#336Surfactant lipids, compositions thereof, and uses thereof
#337LIPID MIXTURE FOR INFANT NUTRITION
#338Compositions and methods for combination antiviral therapy
#339Compositions and methods for combination antiviral therapy
#3406-oxopurine phosphoribosyltransferase inhibitors
#341Nutrition Composition
#342Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate
#343Vesicular formulations
#344USE OF THERAPEUTICALLY EFFECTIVE LIPIDS AND METHOD FOR PRODUCING ORGAN-/TISSUE-SPECIFIC THERAPEUTICALLY EFFECTIVE LIPIDS
#345Lipid compositions with high DHA content
#346Benzimidazolium compounds
#3475-substituted benzimidazolium compounds
#348Pharmaceutical compositions to reduce complications of ocular steroid
#349Bioeffective krill oil compositions
#350Bioeffective krill oil compositions
#351METHOD AND COMPOSITION FOR PHARMACEUTICAL PRODUCT
#352Esters for treatment of ocular inflammatory conditions
#353KRILL OIL AND REACTED ASTAXANTHIN COMPOSITION AND ASSOCIATED METHOD
#354Modulators of toll-like receptors
#355Bicyclic aryl sphingosine 1-phosphate analogs
#356Krill oil and reacted astaxanthin composition and associated method
#357Composition for external use on skin for inflammatory diseases
#358Improving recognition
#359ALGAL OMEGA 7 COMPOSITIONS
#360Compositions and methods for utilization of algal compounds
#361Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
#362COMPOSITIONS AND METHODS FOR COMBINATION ANTIVIRAL THERAPY
#363KRILL AND/OR MARINE EXTRACTS FOR PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES, ARTHRITIS, SKIN CANCER, DIABETES, PREMENSTRUAL SYNDROME AND TRANSDERMAL TRANSPORT
#364Treatment of Infection
#365Concentrated therapeutic phospholipid compositions
#366Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
#367Therapeutic application of parenteral krill oil
#368BRAIN FUNCTION IMPROVING AGENT
#369Lyophilization of synthetic liposomal pulmonary surfactant
#370Lyophilization of synthetic liposomal pulmonary surfactant
#371Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
#372Low side effect pharmaceutical composition containing antituberculosis drugs
#373Unitary pharmaceutical dosage form
#374Bioeffective krill oil compositions
#375Methods for producing bioeffective krill oil compositions
#376NOVEL LEUKOTRIENE RECEPTOR ANTAGONIST
#377CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE
#378Non-medical increase or maintenance of body weight of a mammal
#379DRUG SCREENING METHOD, COMPOSITIONS AND METHODS OF TREATING GLAUCOMA
#380Inhibitors of flaviviridae viruses
#381KRILL OIL AND REACTED ASTAXANTHIN COMPOSITION AND ASSOCIATED METHOD
#382COMPOSITIONS AND METHODS OF TREATING GLAUCOMA
#383Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#384Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
#385METHOD AND COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND DEMENTIAS OF VASCULAR ORIGIN
#386Combined Treatment Utilizing VB-201
#387Surfactant lipids, compositions thereof, and uses thereof
#388Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
#389Substituted pyrazines and their use in the treatment of disease
#390Preparation for the prevention and/or treatment of vascular disorders
#391Method for the removal of subcutaneous fat accumulations by subcutaneous lipolysis by administering a combination of glycyrrhizic acid and soybean phospholipids
#392Anti-cytomegalovirus activity of artemisinin-derived dimers
#393Homogenous suspension of immunopotentiating compounds and uses thereof
#394Infant nutrition for improving fatty acid composition of brain membranes
#395Modulators of toll-like receptors
#396Lipid compositions with high DHA content
#397Liposomes for Preventing the Spread of HIV
#398Esters for treatment of ocular inflammatory conditions
#399Esters for treatment of ocular inflammatory conditions
#400Combined Treatment Utilizing VB-201
#401Methods of reducing virulence in bacteria
#402Omega-3 fatty acid nutriceutical composition and optimization method
#403Surfactant composition
#404OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH
#405Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
#406Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#407VESICULAR FORMULATIONS
#408Bicyclic aryl sphingosine 1-phosphate analogs
#409CONCENTRATION AND MENTAL PERFORMANCE AMPLIFYING FORMULATION
#410Myeloid derived suppressor cell inhibiting agents
#411Inhibitors of viruses
#412METHOD OF EVALUATING SUITABILITY FOR DRUG THERAPY FOR THE PREVENTION AND TREATMENT OF ANXIETY DISORDERS USING CHOLINERGIC TYPE II THETA RHYTHM
#413Composition with anti-inflammatory, protein synthesizing, treatment of enzyme deficiency, activating genetic therapy and anti-cancer activity and methods of use
#414Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
#415TREATMENT OF INFECTION
#416Lipid supplements for maintaining health and treatment of acute and chronic disorders
#417Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
#418PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
#419Krill Extracts for Treatment of Cardiovascular Diseases
#420Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
#421CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE
#422DOCOSAHEXAENOIC ACID BOUND IN PHOSPHOLIPIDS AND METHOD OF RECOVERING SAME FROM A NATURAL SOURCE
#423Nutritional compositions with coated lipid globules
#424Compositions and methods to treat cardiac diseases
#425COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS
#426Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
#427Concentrated therapeutic phospholipid compositions
#428Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
#429COMPOSITIONS COMPRISING PHOSPHOLIPIDS
#430METHOD AND COMPOUND FOR THE TREATMENT OF VALVULAR DISEASE
#431NOVEL LEUKOTRIENE RECEPTOR AGONIST
#432CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE
#433WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS
#434Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder
#435Modulation of the Phospholipase A2 Pathway as a Therapeutic
#436Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
#437Preparation for the prevention and/or treatment of vascular disorders
#438Lipid mixture for infant nutrition
#439Molecular delivery vehicle
#440Cholesterol level lowering liposomes
#441COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS
#442Compositions and methods for treatment of cancer
#443COMPOSITIONS AND TREATMENTS FOR SEIZURE-RELATED DISORDERS
#444FOODSTUFF COMPOSITION TO IMPROVE DIGESTIBILITY OF FOODSTUFF LIPIDS
#445Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#446Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#447Modulators of toll-like receptors
#448DIETARY SUPPLEMENT, ANTI-FATIGUE AGENT OR PHYSICAL ENDURANCE ENHANCER, FUNCTIONAL FOOD, OR COSMETIC
#449Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency
#450METHODS FOR TREATING OR PREVENTING HEMORRHAGIC CYSTITIS USING A GLYCEROPHOSPHATE SALT
#451Thyromimetics for the Treatment of Fatty Liver Diseases
#452Phosphonate analogs of HIV inhibitor compounds
#453Method for the treatment of valvular disease
#454MODULATION OF THE IMMUNE SYSTEM BY INOSITOL PHOSPHOLIPIDS
#455Compositions and methods for combination antiviral therapy
#456Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#457Method of using compatible solutes containing ectoine and/or hydroxyectoine
#458Phospholipids for Use in the Treatment of an Allergic Inflammatory Condition
#459Structured Phospholipids
#460Compositions and methods for combination antiviral therapy
#461Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
#462Composition for reducing the exudation of serum proteins
#463Antiviral compounds
#464Use Of Linoleic Compounds Against Heart Failure
#465PHOSPHOINOSITIDE MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#466ANTI-RESORPTIVE BONE CEMENTS AND ALLOGENEIC, AUTOGRAFIC, AND XENOGRAFIC BONE GRAFTS
#467CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE
#468Bioeffective krill oil compositions
#469Surfactant lipids, compositions thereof and uses thereof
#470Preparation for the prevention and/or treatment of vascular disorders
#471PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#472PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#473Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids
#474PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#475PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#476Water soluble extract of spinach for prevention and repair of DNA damage
#477USE OF PHOSPHOENOLPYRUVATE DERIVATIVES
#478PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#479Lung Surfactant Supplements
#480Inhibition of HIV infection through chemoprophylaxis
#481Preparation for the prevention and/or treatment of vascular disorders
#482METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY
#483Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis
#484Fat composition
#485Unitary pharmaceutical dosage form
#486Krill extracts for treatment of cardiovascular diseases
#487Method and composition for pharmaceutical product
#488Treatment of inflammation and vascular abnormalities of the eye
#489Phosphonate analogs of HIV inhibitor compounds
#490Physiologically active composition based on phosphatidylserine
#491Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism
#492Pulmonary surfactant formulations
#493Pharmaceutical compositions for treating or preventing coronary artery disease
#494Compositions and methods for combination antiviral therapy
#495Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
#496Compositions and methods for combination antiviral therapy
#497Compositions and methods for treatment of cancer
#498Bicyclic heterocycles as HIV integrase inhibitors
#499Charged phospholipid compositions and methods for their use
#500Multiple sclerosis treatment
#501Accelerating recovery from trauma
#502Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
#503Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
#504Biological lubricant composition and method of applying lubricant composition
#505Peptide-carrying bodies for immune response
#506Charged phospholipid compositions and methods for their use
#507Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#508Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease
#509Method of modulating sodium ion absorption in epithelial cells
#510Algal botanical extracts rich in eicosapentaenoic acid as tri/di-glyceride conjugate
#511Omega-3 fatty acid nutriceutical compositions and methods
#512Composition of natural products for improved brain functioning
#513Omega-3 fatty acid nutriceutical composition and optimization method